Ex-Sales and Marketing Exec of Taro Indicted for Price-Fixing
An ex-sales and marketing executive of Taro Pharmaceutical Industries, Ara Aprahamian, has been indicted for price-fixing and bid-rigging, amongst other expenses.
The Justice Division stated that Aprahamian was indicted Tuesday for taking part in two conspiracies to solve generic drug price issues between 2013 and 2015.
Bob Gage, an Aprahamian lawyer, stated that he regarded forward to his day in court. “We’ve absolute confidence that once all the info is brought to light, Mr. Aprahamian will probably be proven innocent,” Gage stated.
Aprahamian was a VP of sales at Taro, according to Connecticut’s Office of Attorney General.
The Division of Justice didn’t respond to questions about Aprahamian’s employment.
He’s additionally charged with lying to an FBI agent when he rejected that he had spoken to a rival about pricing.
The problem of drug pricing has become a hot topic amid stories that some medications, including some on the markets for many years, have seen their costs increase sharply.